{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:18:08Z","timestamp":1785766688673,"version":"3.56.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81690261"],"award-info":[{"award-number":["81690261"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81703450"],"award-info":[{"award-number":["81703450"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.ejps.2018.10.021","type":"journal-article","created":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T02:24:37Z","timestamp":1540261477000},"page":"161-174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["PD-L1 knockdown via hybrid micelle promotes paclitaxel induced Cancer-Immunity Cycle for melanoma treatment"],"prefix":"10.1016","volume":"127","author":[{"given":"Xian","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingdong","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaojie","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9118-5394","authenticated-orcid":false,"given":"Zhirong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0721-7678","authenticated-orcid":false,"given":"Qin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2018.10.021_bb0005","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/adhm.201300597","article-title":"Gold nanoparticles displaying tumor-associated self-antigens as a potential vaccine for cancer immunotherapy","volume":"3","author":"Ahn","year":"2014","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.ejps.2018.10.021_bb0010","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJMra1514296","article-title":"Molecular and biochemical aspects of the PD-1 checkpoint pathway","volume":"375","author":"Boussiotis","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejps.2018.10.021_bb0015","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nrclinonc.2016.58","article-title":"Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination","volume":"13","author":"Boutros","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ejps.2018.10.021_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","article-title":"Oncology meets immunology: the cancer-immunity cycle","volume":"39","author":"Chen","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.ejps.2018.10.021_bb0025","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1038\/mt.2010.34","article-title":"Metronomic chemotherapy enhances antitumor effects of cancer vaccine by depleting regulatory T lymphocytes and inhibiting tumor angiogenesis","volume":"18","author":"Chen","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejps.2018.10.021_bb0030","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.imbio.2011.10.016","article-title":"Interferon-\u03b3-induced PD-L1 surface expression on human oral squamous carcinoma via PKD2 signal pathway","volume":"217","author":"Chen","year":"2012","journal-title":"Immunobiology"},{"key":"10.1016\/j.ejps.2018.10.021_bb0035","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13193","article-title":"Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy","volume":"7","author":"Chen","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejps.2018.10.021_bb0040","article-title":"Biodegradable black phosphorus nanosheets mediate specific delivery of hTERT siRNA for synergistic cancer therapy","author":"Chen","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ejps.2018.10.021_bb0045","doi-asserted-by":"crossref","first-page":"6964","DOI":"10.1158\/0008-5472.CAN-16-0258","article-title":"Tumor-intrinsic PD-L1 signals regulate cell growth, pathogenesis, and autophagy in ovarian cancer and melanoma","volume":"76","author":"Clark","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejps.2018.10.021_bb0050","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/sj.cdd.4402255","article-title":"Decoding dangerous death: how cytotoxic chemotherapy invokes inflammation, immunity or nothing at all","volume":"15","author":"van der Most","year":"2008","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejps.2018.10.021_bb0055","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2012.63","article-title":"Lipidoid nanoparticles containing PD-L1 siRNA delivered in vivo enter Kupffer cells and enhance NK and CD8+ T cell-mediated hepatic antiviral immunity","volume":"2","author":"Dolina","year":"2013","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ejps.2018.10.021_bb0060","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.clim.2009.03.115","article-title":"PD-L1 regulates the development, maintenance, and function of induced regulatory T cells","volume":"131","author":"Francisco","year":"2009","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.ejps.2018.10.021_bb0065","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/mt.2009.91","article-title":"The effect of chemical modification and nanoparticle formulation on stability and biodistribution of siRNA in mice","volume":"17","author":"Gao","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejps.2018.10.021_bb0070","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0092-8674(00)80693-5","article-title":"Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses","volume":"100","author":"Geijtenbeek","year":"2000","journal-title":"Cell"},{"issue":"46","key":"10.1016\/j.ejps.2018.10.021_bb0075","article-title":"PEG-PCL-based nanomedicines: a biodegradable drug delivery system and its application","volume":"260","author":"Grossen","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2018.10.021_bb0080","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/nature06868","article-title":"Vascular normalization in Rgs5-deficient tumours promotes immune destruction","volume":"453","author":"Hamzah","year":"2008","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.ejps.2018.10.021_bb0085","article-title":"Optimization of weight ratio for DSPE-PEG\/TPGS hybrid micelles to improve drug retention and tumor penetration","volume":"35","author":"Jin","year":"2018","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2018.10.021_bb0090","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1479-5876-7-58","article-title":"Chemomodulation of human dendritic cell function by antineoplastic agents in low noncytotoxic concentrations","volume":"7","author":"Kaneno","year":"2009","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ejps.2018.10.021_bb0095","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.cell.2015.08.052","article-title":"Melanoma cell-intrinsic PD-1 receptor functions promote tumor growth","volume":"162","author":"Kleffel","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ejps.2018.10.021_bb0100","doi-asserted-by":"crossref","first-page":"10135","DOI":"10.1021\/acsnano.7b04717","article-title":"Programmed cell death protein ligand-1 silencing with polyethylenimine\u2013dermatan sulfate complex for dual inhibition of melanoma growth","volume":"11","author":"Kwak","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejps.2018.10.021_bb0105","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1504030","article-title":"Combined nivolumab and ipilimumab or monotherapy in untreated melanoma","volume":"373","author":"Larkin","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejps.2018.10.021_bb0110","doi-asserted-by":"crossref","first-page":"7457","DOI":"10.1002\/adfm.201503115","article-title":"Rational design of polymeric hybrid micelles with highly tunable properties to co-deliver microRNA-34a and vismodegib for melanoma therapy","volume":"25","author":"Li","year":"2015","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.ejps.2018.10.021_bb0115","doi-asserted-by":"crossref","first-page":"7457","DOI":"10.1002\/adfm.201503115","article-title":"Rational design of polymeric hybrid micelles with highly tunable properties to co-deliver microRNA-34a and vismodegib for melanoma therapy","volume":"25","author":"Li","year":"2016","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.ejps.2018.10.021_bb0120","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1172\/JCI96113","article-title":"Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade-mediated tumor regression","volume":"128","author":"Lin","year":"2018","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejps.2018.10.021_bb0125","doi-asserted-by":"crossref","first-page":"17582","DOI":"10.1021\/acsami.8b02954","article-title":"Enhanced tumor retention effect by click chemistry for improved cancer immunochemotherapy","volume":"10","author":"Mei","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ejps.2018.10.021_bb0130","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1158\/2159-8290.CD-13-0985","article-title":"T-cell and NK-cell infiltration into solid tumors: a key limiting factor for efficacious cancer immunotherapy","volume":"4","author":"Melero","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ejps.2018.10.021_bb0135","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.4049\/jimmunol.0902960","article-title":"Dendritic cell (DC)-specific targeting reveals Stat3 as a negative regulator of DC function","volume":"184","author":"Melillo","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejps.2018.10.021_bb0140","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1158\/0008-5472.CAN-12-2731","article-title":"Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses","volume":"73","author":"Mitchem","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejps.2018.10.021_bb0145","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejps.2018.10.021_bb0150","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cellimm.2010.03.001","article-title":"Paclitaxel enhances early dendritic cell maturation and function through TLR4 signaling in mice","volume":"263","author":"Pfannenstiel","year":"2010","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.ejps.2018.10.021_bb0155","doi-asserted-by":"crossref","first-page":"13033","DOI":"10.1039\/C6NR04034A","article-title":"Systemic delivery of siRNA by hyaluronan-functionalized calcium phosphate nanoparticles for tumor-targeted therapy","volume":"8","author":"Qiu","year":"2016","journal-title":"Nanoscale"},{"key":"10.1016\/j.ejps.2018.10.021_bb0160","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1172\/JCI40269","article-title":"Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice","volume":"120","author":"Ramakrishnan","year":"2010","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejps.2018.10.021_bb0165","doi-asserted-by":"crossref","first-page":"5483","DOI":"10.1158\/0008-5472.CAN-12-2236","article-title":"Autophagy induced by conventional chemotherapy mediates tumor cell sensitivity to immunotherapy","volume":"72","author":"Ramakrishnan","year":"2013","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.ejps.2018.10.021_bb0170","doi-asserted-by":"crossref","DOI":"10.1186\/1750-9378-7-1","article-title":"mTOR inhibitors: a novel class of anti-cancer agents","volume":"7","author":"Riaz","year":"2012","journal-title":"Infect. Agent Cancer"},{"key":"10.1016\/j.ejps.2018.10.021_bb0175","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.oraloncology.2014.11.014","article-title":"Intrinsic and extrinsic control of expression of the immunoregulatory molecule PD-L1 in epithelial cells and squamous cell carcinoma","volume":"51","author":"Ritprajak","year":"2015","journal-title":"Oral Oncol."},{"key":"10.1016\/j.ejps.2018.10.021_bb0180","doi-asserted-by":"crossref","first-page":"7992","DOI":"10.1016\/j.biomaterials.2014.05.076","article-title":"Poly (\u03b3-glutamic acid) based combination of water-insoluble paclitaxel and TLR7 agonist for chemo-immunotherapy","volume":"35","author":"Seth","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejps.2018.10.021_bb0185","doi-asserted-by":"crossref","first-page":"6171","DOI":"10.1158\/0008-5472.CAN-10-0153","article-title":"Antiangiogenic agents can increase lymphocyte infiltration into tumor and enhance the effectiveness of adoptive immunotherapy of cancer","volume":"70","author":"Shrimali","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejps.2018.10.021_bb0190","doi-asserted-by":"crossref","first-page":"6366","DOI":"10.1021\/acs.nanolett.7b03186","article-title":"Tumor microenvironment responsive nanogel for the combinatorial antitumor effect of chemotherapy and immunotherapy","volume":"17","author":"Song","year":"2017","journal-title":"Nano Lett."},{"key":"10.1016\/j.ejps.2018.10.021_bb0195","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/ijc.30708","article-title":"Recent developments in nanomedicine for melanoma treatment","volume":"141","author":"Tang","year":"2017","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejps.2018.10.021_bb0200","doi-asserted-by":"crossref","first-page":"6529","DOI":"10.1039\/C6NR09895A","article-title":"Paclitaxel nanoparticle awakens immune system to fight against cancer","volume":"9","author":"Tang","year":"2017","journal-title":"Nanoscale"},{"key":"10.1016\/j.ejps.2018.10.021_bb0205","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/adhm.201500089","article-title":"Ovarian cancer immunotherapy using PD-L1 siRNA targeted delivery from folic acid-functionalized polyethylenimine: strategies to enhance T cell killing","volume":"4","author":"Teo","year":"2015","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.ejps.2018.10.021_bb0210","doi-asserted-by":"crossref","first-page":"9331","DOI":"10.1073\/pnas.0710441105","article-title":"Programmed death 1 ligand signaling regulates the generation of adaptive Foxp3+CD4+ regulatory T cells","volume":"105","author":"Wang","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejps.2018.10.021_bb0215","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.7150\/thno.16184","article-title":"A new concept of enhancing immuno-chemotherapeutic effects against B16F10 tumor via systemic administration by taking advantages of the limitation of EPR effect","volume":"6","author":"Yang","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.ejps.2018.10.021_bb0220","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.clim.2008.07.013","article-title":"Differential impairment of regulatory T cells rather than effector T cells by paclitaxel-based chemotherapy","volume":"129","author":"Zhang","year":"2008","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.ejps.2018.10.021_bb0225","doi-asserted-by":"crossref","first-page":"17047","DOI":"10.1073\/pnas.1304987110","article-title":"Enhanced anticancer activity of nanopreparation containing an MMP2-sensitive PEG-drug conjugate and cell-penetrating moiety","volume":"110","author":"Zhu","year":"2013","journal-title":"Proc. Natl. Acad. Sci."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098718304688?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098718304688?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:48:04Z","timestamp":1760528884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098718304688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":45,"alternative-id":["S0928098718304688"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2018.10.021","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PD-L1 knockdown via hybrid micelle promotes paclitaxel induced Cancer-Immunity Cycle for melanoma treatment","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2018.10.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}